PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 130 filers reported holding PROVENTION BIO INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,824,353 | +798.5% | 864,081 | +294.1% | 0.00% | +300.0% |
| Q4 2022 | $2,317,683 | +128.6% | 219,270 | -2.7% | 0.00% | – |
| Q3 2022 | $1,014,000 | -25.8% | 225,323 | -34.1% | 0.00% | – |
| Q2 2022 | $1,367,000 | -23.3% | 341,711 | +40.2% | 0.00% | – |
| Q1 2022 | $1,783,000 | +17.7% | 243,691 | -9.6% | 0.00% | – |
| Q4 2021 | $1,515,000 | +13.1% | 269,580 | +28.8% | 0.00% | – |
| Q3 2021 | $1,339,000 | -52.2% | 209,237 | -37.1% | 0.00% | -100.0% |
| Q2 2021 | $2,804,000 | -21.5% | 332,600 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $3,573,000 | +189.1% | 340,506 | +366.5% | 0.00% | – |
| Q4 2020 | $1,236,000 | -28.1% | 72,989 | -45.5% | 0.00% | – |
| Q3 2020 | $1,719,000 | +14.3% | 133,917 | +25.6% | 0.00% | – |
| Q2 2020 | $1,504,000 | +56.8% | 106,615 | +2.3% | 0.00% | – |
| Q1 2020 | $959,000 | +2563.9% | 104,240 | +562.8% | 0.00% | – |
| Q1 2019 | $36,000 | +2.9% | 15,727 | -20.3% | 0.00% | – |
| Q4 2018 | $35,000 | -60.2% | 19,735 | -9.9% | 0.00% | – |
| Q3 2018 | $88,000 | – | 21,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |